Le Biomedical Corp. Lebm 昇級生醫 股

LE Biomedical Corp.(LEBM) is a Taiwan-based AI healthtech company building next-generation infrastructure for pharmacy operations, healthcare innovation, and AI-enabled biomedical solutions. Our flagship platform, PharmaDemand AI, is an AI-native demand forecasting and replenishment optimization solution purpose-built for pharmacies. It combines historical POS data, inventory signals, and Consumer Digital Twin intelligence to generate probabilistic 7 / 30 / 90-day SKU-level demand forecasts and smarter reorder recommendations. We focus on one of the hardest problems in pharmacy retail: • reducing stockout risk • lowering expiry-related waste • improving inventory turnover • supporting better store-level inventory decisions Unlike generic retail AI, our approach is designed for pharmacy-specific complexity, including long-tail SKUs, substitution effects, censored demand from stockouts, and expiry constraints. In 2026, LEBM introduced PharmaDemand AI at SusHi Tech Tokyo 2026 as part of the Taiwan startup delegation. We are expanding from Taiwan into Japan and actively seeking pharmacy chain partners, strategic investors, and technology collaborators for pilot projects and market deployment based in Taipei and Tokyo.